Mirae Asset Global ETFs Holdings’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$140K Buy
20,869
+510
+3% +$2.93K ﹤0.01% 2527
2025
Q4
$111K Sell
20,359
-44
-0.2% -$261 ﹤0.01% 2628
2025
Q3
$126K Sell
20,403
-117
-0.6% -$765 ﹤0.01% 2562
2025
Q2
$128K Sell
20,520
-7,218
-26% -$42.2K ﹤0.01% 2482
2025
Q1
$163K Buy
27,738
+1,170
+4% +$8.85K ﹤0.01% 2416
2024
Q4
$218K Buy
26,568
+1,140
+4% +$10.7K ﹤0.01% 2353
2024
Q3
$227K Buy
25,428
+7,531
+42% +$64.6K ﹤0.01% 2315
2024
Q2
$135K Buy
+17,897
New +$131K ﹤0.01% 2444

Other funds holding AURA

Mirae Asset Global ETFs Holdings's AURA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Aura Biosciences (AURA) stake by 2.5% in Q1 2026, buying an estimated $2.93K and bringing the position to 20,869 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Mirae Asset Global ETFs Holdings first reported a position in AURA in Q2 2024 and has held it in 8 quarters since. The position peaked at $227K in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 20,869 shares of Aura Biosciences worth $140K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 510 Aura Biosciences shares in Q1 2026, an estimated $2.93K.
  • Aura Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2527 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Aura Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Aura Biosciences position peaked at $227K in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.